U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H11Cl2NO3
Molecular Weight 312.148
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 4'-HYDROXYDICLOFENAC

SMILES

OC(=O)CC1=CC=CC=C1NC2=C(Cl)C=C(O)C=C2Cl

InChI

InChIKey=KGVXVPRLBMWZLG-UHFFFAOYSA-N
InChI=1S/C14H11Cl2NO3/c15-10-6-9(18)7-11(16)14(10)17-12-4-2-1-3-8(12)5-13(19)20/h1-4,6-7,17-18H,5H2,(H,19,20)

HIDE SMILES / InChI

Molecular Formula C14H11Cl2NO3
Molecular Weight 312.148
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

4'-Hydroxy diclofenac, a metabolite of diclofenac, suppresses prostaglandin E2 production specifically by blocking cyclooxygenase-2 activity and demonstrates anti-inflammatory properties.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P35354
Gene ID: 5743.0
Gene Symbol: PTGS2
Target Organism: Homo sapiens (Human)
0.54 µM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline.
2001 Feb
Effects of phenobarbital on metabolism and toxicity of diclofenac sodium in rat hepatocytes in vitro.
2004 Oct
Preparative synthesis of drug metabolites using human cytochrome P450s 3A4, 2C9 and 1A2 with NADPH-P450 reductase expressed in Escherichia coli.
2005 Feb
Development and validation of a high-throughput radiometric cyp2c9 inhibition assay using tritiated diclofenac.
2005 Mar
Efficient high performance liquid chromatograph/ultraviolet method for determination of diclofenac and 4'-hydroxydiclofenac in rat serum.
2006 Jan 18
[The inhibition of CYP2C9 isoenzyme in Cunninghamella blakesleeana AS 3. 910].
2006 Oct
Effect of methamphetamine on cytochrome P450 activity.
2007 Dec
Investigation of the immunogenicity of diclofenac and diclofenac metabolites.
2007 Jan 10
High-throughput cytochrome P450 inhibition assays using laser diode thermal desorption-atmospheric pressure chemical ionization-tandem mass spectrometry.
2007 Jun 15
Analytical approaches to determine cytochrome P450 inhibitory potential of new chemical entities in drug discovery.
2007 May 1
Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy.
2008 Apr 15
Simultaneous determination of aceclofenac and its three metabolites in plasma using liquid chromatography-tandem mass spectrometry.
2008 Feb 13
Isolation and characterization of a new human urinary metabolite of diclofenac applying LC-NMR-MS and high-resolution mass analyses.
2008 Jun 9
First evidence for occurrence of hydroxylated human metabolites of diclofenac and aceclofenac in wastewater using QqLIT-MS and QqTOF-MS.
2008 Nov 1
Occurrence of diclofenac and selected metabolites in sewage effluents.
2008 Nov 1
Regioselective preparation of 5-hydroxypropranolol and 4'-hydroxydiclofenac with a fungal peroxygenase.
2009 Jun 1
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro.
2010
Hepatic clearance of reactive glucuronide metabolites of diclofenac in the mouse is dependent on multiple ATP-binding cassette efflux transporters.
2010 Apr
Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR.
2010 Apr 15
Identification and characterization of a bacterial cytochrome P450 for the metabolism of diclofenac.
2010 Jan
Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites.
2010 Oct 28
Role of drug-independent stress factors in liver injury associated with diclofenac intake.
2013 Oct 4
Histone deacetylase inhibitor valproic acid promotes the differentiation of human induced pluripotent stem cells into hepatocyte-like cells.
2014
Human NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated inactivation of reactive quinoneimine metabolites of diclofenac and mefenamic acid.
2014 Apr 21
One-electron oxidation of diclofenac by human cytochrome P450s as a potential bioactivation mechanism for formation of 2'-(glutathion-S-yl)-deschloro-diclofenac.
2014 Jan 25
Patents

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
Effects of aceclofenac and its metabolite, 4′-hydroxyaceclofenac on prostaglandin E2 (PGE2) production by rheumatoid synovial cells were studies. First-passage synovial cells (106 cells/ml) from 10 patients with rheumatoid arthritis were cultured in the presence of aceclofenac and 4′-hydroxyaceclofenac in range of concentration: 0.0001 – 100 uM. After 24 h in culture, amount of PGE2 in culture medium was measured by enzyme immunoassay. It was found, that diclofenac and 4′-hydroxydiclofenac suppressed PGE2 production, with IC50 values of 1.3 ± 0.6 nM (n = 10) and 16.9 ± 8.5 nM (n= 9), respectively.
Substance Class Chemical
Created
by admin
on Thu Jul 06 01:13:29 UTC 2023
Edited
by admin
on Thu Jul 06 01:13:29 UTC 2023
Record UNII
NJF5O599EF
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
4'-HYDROXYDICLOFENAC
Common Name English
BENZENEACETIC ACID, 2-((2,6-DICHLORO-4-HYDROXYPHENYL)AMINO)-
Systematic Name English
4'-HYDROXY-DICLOFENAC
Common Name English
HYDROXYDICLOFENAC, 4'-
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID40214326
Created by admin on Thu Jul 06 01:13:29 UTC 2023 , Edited by admin on Thu Jul 06 01:13:29 UTC 2023
PRIMARY
CAS
64118-84-9
Created by admin on Thu Jul 06 01:13:29 UTC 2023 , Edited by admin on Thu Jul 06 01:13:29 UTC 2023
PRIMARY
FDA UNII
NJF5O599EF
Created by admin on Thu Jul 06 01:13:29 UTC 2023 , Edited by admin on Thu Jul 06 01:13:29 UTC 2023
PRIMARY
PUBCHEM
116545
Created by admin on Thu Jul 06 01:13:29 UTC 2023 , Edited by admin on Thu Jul 06 01:13:29 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> METABOLITE LESS ACTIVE
MAJOR